Home › Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse
 

Keywords :   


Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse

2015-09-30 08:19:49| drugdiscoveryonline News Articles

Sosei Group Corporation is pleased to announce that its wholly-owned subsidiary Heptares Therapeutics (“Heptares”) has been awarded a grant from the National Institute on Drug Abuse (NIDA), one of the US National Institutes of Health

Tags: research development national abuse

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Wind Speed Probabilities Number 6
30.06Hurricane Beryl Public Advisory Number 6
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Forecast Advisory Number 6
30.06The big problem facing whoever wins the election
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 5A
More »